REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 171 filers reported holding REGENXBIO INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,286,320 | -16.9% | 381,915 | +0.9% | 0.00% | 0.0% |
Q2 2023 | $7,562,737 | +21.7% | 378,326 | +15.1% | 0.00% | 0.0% |
Q1 2023 | $6,213,163 | -11.6% | 328,565 | +6.0% | 0.00% | 0.0% |
Q4 2022 | $7,030,096 | -23.6% | 309,969 | -10.9% | 0.00% | 0.0% |
Q3 2022 | $9,201,000 | -26.5% | 348,073 | -31.3% | 0.00% | -50.0% |
Q2 2022 | $12,517,000 | -6.6% | 506,748 | +25.5% | 0.00% | 0.0% |
Q1 2022 | $13,403,000 | -5.6% | 403,847 | -7.0% | 0.00% | 0.0% |
Q4 2021 | $14,200,000 | -0.7% | 434,267 | +27.3% | 0.00% | 0.0% |
Q3 2021 | $14,301,000 | -21.1% | 341,156 | -26.9% | 0.00% | 0.0% |
Q2 2021 | $18,136,000 | +102.5% | 466,828 | +77.8% | 0.00% | +100.0% |
Q1 2021 | $8,954,000 | +8.4% | 262,488 | +44.1% | 0.00% | 0.0% |
Q4 2020 | $8,263,000 | -3.7% | 182,179 | -41.6% | 0.00% | -50.0% |
Q3 2020 | $8,582,000 | +23.4% | 311,852 | +65.1% | 0.00% | 0.0% |
Q2 2020 | $6,956,000 | +38.9% | 188,880 | +22.1% | 0.00% | +100.0% |
Q1 2020 | $5,008,000 | -47.3% | 154,700 | -33.3% | 0.00% | -50.0% |
Q4 2019 | $9,502,000 | +34.8% | 231,898 | +17.1% | 0.00% | 0.0% |
Q3 2019 | $7,051,000 | -45.5% | 198,046 | -21.4% | 0.00% | -33.3% |
Q2 2019 | $12,943,000 | +184.8% | 251,959 | +217.7% | 0.00% | +200.0% |
Q1 2019 | $4,544,000 | -64.5% | 79,306 | -74.0% | 0.00% | -75.0% |
Q4 2018 | $12,782,000 | -40.0% | 304,693 | +8.1% | 0.00% | -20.0% |
Q3 2018 | $21,289,000 | -13.6% | 281,968 | -17.9% | 0.01% | -28.6% |
Q2 2018 | $24,634,000 | +185.4% | 343,343 | +18.8% | 0.01% | +250.0% |
Q1 2018 | $8,630,000 | +32.6% | 289,112 | +47.7% | 0.00% | 0.0% |
Q4 2017 | $6,509,000 | +255.9% | 195,755 | +252.7% | 0.00% | +100.0% |
Q3 2017 | $1,829,000 | +36.1% | 55,507 | -18.5% | 0.00% | – |
Q2 2017 | $1,344,000 | -18.1% | 68,072 | -19.9% | 0.00% | – |
Q1 2017 | $1,642,000 | -39.3% | 85,012 | -41.7% | 0.00% | – |
Q4 2016 | $2,706,000 | +698.2% | 145,840 | +505.0% | 0.00% | – |
Q3 2016 | $339,000 | +474.6% | 24,106 | +225.4% | 0.00% | – |
Q2 2016 | $59,000 | -33.7% | 7,407 | -10.3% | 0.00% | – |
Q1 2016 | $89,000 | -68.9% | 8,258 | -51.9% | 0.00% | – |
Q4 2015 | $286,000 | +217.8% | 17,186 | +319.5% | 0.00% | – |
Q3 2015 | $90,000 | – | 4,097 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |